Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (201-210 of 272) with videos related to

Pageof 28
Sort By:
Brain, Behavior, and Immunity|June 20, 2014
Attachment anxiety is related to Epstein-Barr virus latencyChristopher P Fagundes, Lisa M Jaremka, Ronald Glaser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapyJonathan P Butchar, Payal Mehta, Steven E Justiniano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
A phase I trial of bortezomib and interferon-α-2b in metastatic melanomaJoseph Markowitz, Eric A Luedke, Valerie P Grignol, et al.
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.
Iscience|June 5, 2023
CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cellsCho-Hao Lin, Fatemeh Talebian, Yang Li, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2019
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanomaLorena P Suarez-Kelly, Kala M Levine, Thomas E Olencki, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|October 19, 2011
Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancerChristopher P Fagundes, Jeanette M Bennett, Catherine M Alfano, et al.
Science Signaling|April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathwayAnn-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Cancer Research|June 18, 2011
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing miceBethany L Mundy-Bosse, Gregory B Lesinski, Alena C Jaime-Ramirez, et al.
Oncoimmunology|June 23, 2017
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptorElizabeth L McMichael, Nicholas B Courtney, Megan C Duggan, et al.
Pageof 28

Showing results (201-210 of 272) with videos related to

Sort By:
Pageof 28
Brain, Behavior, and Immunity|June 20, 2014
Attachment anxiety is related to Epstein-Barr virus latencyChristopher P Fagundes, Lisa M Jaremka, Ronald Glaser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapyJonathan P Butchar, Payal Mehta, Steven E Justiniano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
A phase I trial of bortezomib and interferon-α-2b in metastatic melanomaJoseph Markowitz, Eric A Luedke, Valerie P Grignol, et al.
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.
Iscience|June 5, 2023
CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cellsCho-Hao Lin, Fatemeh Talebian, Yang Li, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2019
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanomaLorena P Suarez-Kelly, Kala M Levine, Thomas E Olencki, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|October 19, 2011
Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancerChristopher P Fagundes, Jeanette M Bennett, Catherine M Alfano, et al.
Science Signaling|April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathwayAnn-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Cancer Research|June 18, 2011
Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing miceBethany L Mundy-Bosse, Gregory B Lesinski, Alena C Jaime-Ramirez, et al.
Oncoimmunology|June 23, 2017
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptorElizabeth L McMichael, Nicholas B Courtney, Megan C Duggan, et al.
Pageof 28